|
Jul 13
|
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
|
|
Jun 27
|
Despite shrinking by US$188m in the past week, TG Therapeutics (NASDAQ:TGTX) shareholders are still up 427% over 1 year
|
|
May 2
|
Q1 2023 TG Therapeutics Inc Earnings Call
|
|
May 1
|
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
|
|
May 1
|
Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets
|
|
May 1
|
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 1
|
TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
|
|
Apr 28
|
TG Therapeutics to Host Conference Call on First Quarter 2023 Financial Results and Business Update
|
|
Apr 27
|
TG Therapeutics Announces Issuance of Permanent J-Code for BRIUMVI® (ublituximab-xiiy) from Centers for Medicare and Medicaid Services
|